Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

A new anti-CD22 CAR T immunotherapy for paediatric leukaemia

Dr Jing Pan - Beijing Boren Hospital, Beijing, China

A new anti-CD22 CAR T immunotherapy for paediatric leukaemia ( Dr Jing Pan - Beijing Boren Hospital, Beijing, China )

EHA Topics in focus : Immunotherapy

Prof John Gribben - Barts Cancer Institute, London, United Kingdom

EHA Topics in focus : Immunotherapy ( Prof John Gribben - Barts Cancer Institute, London, United Kingdom )

Novel ADC for relapsed/refractory lymphoma

Dr Laurie Sehn - BC Cancer Agency, Vancouver, Canada

$Novel ADC for relapsed/refractory lymphoma ( Dr Laurie Sehn - BC Cancer Agency, Vancouver, Canada )$

iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia

Dr Meletios Dimopoulos - National and Kapodistrian University of Athens School...

iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia ( Dr Meletios Dimopoulos - National and Kapodistrian University of Athens School of Medicine, Athens, Greece )

Updated results from a phase I trial of CAR-T cell therapy for r/rMM

Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA

Updated results from a phase I trial of CAR-T cell therapy for r/rMM ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )

Updates from Myeloma XI trial

Dr Charlotte Pawlyn - The Institute of Cancer Research, London, UK

Updates from Myeloma XI trial ( Dr Charlotte Pawlyn - The Institute of Cancer Research, London, UK )

Ribosomal lesions promote oncogenic mutagenesis

Dr Sergey Sulima - Katholieke Universiteit Leuven, Lueven, Belgium

Ribosomal lesions promote oncogenic mutagenesis ( Dr Sergey Sulima - Katholieke Universiteit Leuven, Lueven, Belgium )

Updated data from the FORTE trial of carfilzomib plus lenalidomide or...

Dr Francesca Gay - University of Torino, Torino, Italy

Updated data from the FORTE trial of carfilzomib plus lenalidomide or cyclophosphamide for myeloma ( Dr Francesca Gay - University of Torino, Torino, Italy )

Results from the phase I ICONIC trial

Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA

Results from the phase I ICONIC trial ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )

Phase II results of olaparib and abiraterone for mCRPC

Prof Noel Clarke - Salford Royal NHS Foundation Trust, Salford, UK

Phase II results of olaparib and abiraterone for mCRPC ( Prof Noel Clarke - Salford Royal NHS Foundation Trust, Salford, UK )

Global treatment pattern variations in HCC

Dr Nahum Mendez-Sanchez - Medica Sur Clinic and Foundation, Mexico City, Mexico

Global treatment pattern variations in HCC ( Dr Nahum Mendez-Sanchez - Medica Sur Clinic and Foundation, Mexico City, Mexico )

Design and interim safety analysis of GeparX trial

Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany

Design and interim safety analysis of GeparX trial ( Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany )

More from ecancer